Since the beginning of COVID-19 pandemic the Real Time sharing of genome sequences
of circulating virus supported the diagnostics and surveillance of SARS-CoV-2 and its …

Background. We evaluated reliability and clinical usefulness of genotypic resistance testing (GRT)
in patients for whom combination antiretroviral therapy (cART) was unsuccessful with …

Background We evaluated the prevalence of transmitted drug resistance (TDR) to integrase
strand-transfer inhibitors (INSTIs) and nucleoside/nucleotide reverse transcriptase inhibitors (…

The efficacy on the Omicron variant of the approved early coronavirus disease‐2019 (COVID‐19)
therapies, especially monoclonal antibodies, has been challenged by in vitro …

With numbers of COVID-19 cases having substantially increased at the end of 2022 in China,
some countries have started or expanded testing and genomic surveillance of travellers. …

Whole‐genome sequencing (WGS) has been widely used for the genomic characterization
and the phylogenesis of mpox virus (MPXV) 2022 multi‐country outbreak. To date, no …

Monoclonal antibody (mAb) therapy is one of the most promising immunotherapies that have
shown the potential to prevent or neutralize the effects of COVID-19 in patients at very early …

Specific HBsAg mutations are known to hamper HBsAg recognition by neutralizing antibodies
thus challenging HBV-vaccination efficacy. Nevertheless, information on their impact and …

Objectives To define whether the prevalence of mutations associated with integrase
inhibitor (INI) resistance is different in untreated versus antiretroviral-treated HIV-1-infected …

Background. The dynamics of raltegravir-resistant variants and their impact on virologic
response in 23 HIV-1–infected patients, who started a salvage raltegravir-containing regimen, …